Decipher Bioscineces
Latest round
- Series B
Last raised
- Sep 2013
Total raised
- Undisclosed
Investors
- 4
About Decipher Bioscineces
Decipher Biosciences, Inc.Decipher Biosciences, Inc. operates in the field of genomic testing for urologic cancers, focusing on personalized treatment approaches. Founded in 2008 and headquartered in Vancouver, Canada, the company was involved in a significant acquisition in February 2021 when Veracyte, Inc. acquired it for USD 250 million in cash and USD 350 million in stock. The acquisition indicates a strategic pivot to enhance Veracyte's portfolio in precision medicine. The company has recorded a total of 8 deals, with its most recent deal occurring on February 3, 2021.Decipher Biosciences, Inc. provides genomic tests designed specifically for urologic cancers, including its signature tests: Decipher® Prostate and Decipher® Bladder. The Decipher Prostate test offers actionable insights for treatment decisions in localized prostate cancer, while Decipher Bladder assists in informed treatment planning for bladder cancer.Decipher Biosciences, Inc. derives revenue from its laboratory-developed tests (LDTs), specifically the Decipher Prostate and Decipher Bladder tests. The company engages directly with healthcare providers, who order these tests for their patients, and receives payment for each test conducted. The resulting comprehensive reports facilitate clinical decision-making.Following its acquisition by Veracyte, Inc. in February 2021, Decipher Biosciences, Inc. is poised to leverage the financial backing from the deal to enhance its product offerings and expand its market reach. The company is expected to focus on launching new genomic tests targeting additional urologic cancers by 2023, thereby broadening its service portfolio.
Who invested in Decipher Bioscineces
4 investors across 2 rounds
See all investors in Decipher Bioscineces
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Decipher Bioscineces
Who invested in Decipher Bioscineces?
Decipher Bioscineces has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Decipher Bioscineces raised?
Decipher Bioscineces has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Decipher Bioscineces last raise money?
Decipher Bioscineces's most recent round on record is a Series B, in Sep 2013.
What does Decipher Bioscineces do?
Decipher Bioscineces is a biotechnology company.
Where is Decipher Bioscineces headquartered?
Decipher Bioscineces is headquartered in Vancouver, Canada.
Which VCs invest in companies like Decipher Bioscineces?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Decipher Bioscineces's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Decipher Bioscineces? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.